scientific-nci60-screening

To analyze NCI-60 drug sensitivity with DepMap scores, this Skill integrates CellMiner GI50/LC50 data with dependency scores to identify drug response patterns across cancer cell lines. It cross-references datasets to pinpoint compound sensitivity trends for molecular marker prioritization.

Correlating biomarkers with GI50 drug response data requires integrating CellMiner molecular features with NCI-60 screening results. This Skill computes correlations between molecular markers and drug sensitivity values to prioritize compounds for further study.

Yes, you can compare NCI-60 panel screening results directly with DepMap data. The Skill performs cross-panel comparisons between NCI-60 GI50/LC50 metrics and DepMap dependency scores to highlight overlapping or divergent cancer cell line responses.

Yes, internet access is required to fetch CellMiner and NCI-60 screening data for analysis. The Skill connects to public data sources to retrieve GI50, LC50, and DepMap dependency scores for Python-based analytics.

To retrieve integrated drug screening results using an NSC ID, invoke the pipeline with that specific drug identifier. The Skill fetches corresponding NCI-60 and DepMap data to produce a unified drug sensitivity and dependency report.